QURE
Price
$61.01
Change
+$1.68 (+2.83%)
Updated
Oct 24 closing price
Capitalization
3.76B
3 days until earnings call
Intraday Buy/Sell Signals
TVTX
Price
$28.06
Change
-$0.09 (-0.32%)
Updated
Oct 24 closing price
Capitalization
2.5B
4 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

QURE vs TVTX

Header iconQURE vs TVTX Comparison
Open Charts QURE vs TVTXBanner chart's image
uniQure
Price$61.01
Change+$1.68 (+2.83%)
Volume$1.01M
Capitalization3.76B
Travere Therapeutics
Price$28.06
Change-$0.09 (-0.32%)
Volume$1.31M
Capitalization2.5B
QURE vs TVTX Comparison Chart in %
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
QURE vs. TVTX commentary
Oct 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QURE is a Hold and TVTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 26, 2025
Stock price -- (QURE: $61.01 vs. TVTX: $28.06)
Brand notoriety: QURE and TVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: QURE: 25% vs. TVTX: 59%
Market capitalization -- QURE: $3.76B vs. TVTX: $2.5B
QURE [@Biotechnology] is valued at $3.76B. TVTX’s [@Biotechnology] market capitalization is $2.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QURE’s FA Score shows that 0 FA rating(s) are green whileTVTX’s FA Score has 0 green FA rating(s).

  • QURE’s FA Score: 0 green, 5 red.
  • TVTX’s FA Score: 0 green, 5 red.
According to our system of comparison, TVTX is a better buy in the long-term than QURE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QURE’s TA Score shows that 4 TA indicator(s) are bullish while TVTX’s TA Score has 4 bullish TA indicator(s).

  • QURE’s TA Score: 4 bullish, 6 bearish.
  • TVTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, TVTX is a better buy in the short-term than QURE.

Price Growth

QURE (@Biotechnology) experienced а +5.19% price change this week, while TVTX (@Biotechnology) price change was +2.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.97%. For the same industry, the average monthly price growth was +11.13%, and the average quarterly price growth was +63.98%.

Reported Earning Dates

QURE is expected to report earnings on Oct 29, 2025.

TVTX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+0.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QURE($3.76B) has a higher market cap than TVTX($2.5B). QURE YTD gains are higher at: 245.470 vs. TVTX (61.079). TVTX has higher annual earnings (EBITDA): -107.65M vs. QURE (-119.56M). QURE has more cash in the bank: 377M vs. TVTX (320M). QURE has less debt than TVTX: QURE (66.7M) vs TVTX (400M). TVTX has higher revenues than QURE: TVTX (334M) vs QURE (14.3M).
QURETVTXQURE / TVTX
Capitalization3.76B2.5B150%
EBITDA-119.56M-107.65M111%
Gain YTD245.47061.079402%
P/E RatioN/AN/A-
Revenue14.3M334M4%
Total Cash377M320M118%
Total Debt66.7M400M17%
FUNDAMENTALS RATINGS
QURE vs TVTX: Fundamental Ratings
QURE
TVTX
OUTLOOK RATING
1..100
8768
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
6474
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3438
P/E GROWTH RATING
1..100
9139
SEASONALITY SCORE
1..100
46n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QURE's Valuation (74) in the Biotechnology industry is in the same range as TVTX (88). This means that QURE’s stock grew similarly to TVTX’s over the last 12 months.

QURE's Profit vs Risk Rating (64) in the Biotechnology industry is in the same range as TVTX (74). This means that QURE’s stock grew similarly to TVTX’s over the last 12 months.

QURE's SMR Rating (100) in the Biotechnology industry is in the same range as TVTX (100). This means that QURE’s stock grew similarly to TVTX’s over the last 12 months.

QURE's Price Growth Rating (34) in the Biotechnology industry is in the same range as TVTX (38). This means that QURE’s stock grew similarly to TVTX’s over the last 12 months.

TVTX's P/E Growth Rating (39) in the Biotechnology industry is somewhat better than the same rating for QURE (91). This means that TVTX’s stock grew somewhat faster than QURE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QURETVTX
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 14 days ago
76%
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 5 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
80%
Aroon
ODDS (%)
Bullish Trend 3 days ago
68%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CDEYX19.000.14
+0.74%
Columbia Intrinsic Value Institutional 3
TIBMX32.210.17
+0.53%
Thornburg Investment Income Builder R5
PSKCX45.870.23
+0.50%
Virtus KAR Mid-Cap Growth C
AUXFX32.900.05
+0.15%
Auxier Focus Inv
VELAX17.54N/A
N/A
VELA Large Cap Plus A

QURE and

Correlation & Price change

A.I.dvisor indicates that over the last year, QURE has been loosely correlated with NEVPF. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if QURE jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QURE
1D Price
Change %
QURE100%
+2.83%
NEVPF - QURE
50%
Loosely correlated
N/A
AXON - QURE
42%
Loosely correlated
+2.73%
LXEO - QURE
39%
Loosely correlated
+2.56%
NAMS - QURE
37%
Loosely correlated
-1.56%
MLTX - QURE
37%
Loosely correlated
+0.63%
More

TVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVTX has been loosely correlated with RCUS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TVTX jumps, then RCUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVTX
1D Price
Change %
TVTX100%
-0.32%
RCUS - TVTX
41%
Loosely correlated
+3.16%
ARWR - TVTX
40%
Loosely correlated
+1.74%
ROIV - TVTX
38%
Loosely correlated
+0.55%
VCYT - TVTX
37%
Loosely correlated
+3.06%
CGON - TVTX
37%
Loosely correlated
+4.03%
More